A Study of Brenipatide in Adult Participants With Schizophrenia (NCT07410507)
A Phase 2 Multicenter, Double-Blind, Parallel-Arm Study to Investigate the Efficacy and Safety of Adjunctive Treatment With Brenipatide in Adult Participants With Schizophrenia (RENEW-Scz-1)
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to assess the efficacy and safety of brenipatide when administered with standard of care (SoC) compared to placebo plus SoC for treatment of schizophrenia. The trial is divided into three periods as follows: Screening period will last approximately 1 month, treatment period will last a maximum of 12 months, and the follow up period will last approximately 2 months. The length of time of your study participation may last up to approximately 15 months.
Who can join: Review the eligibility criteria below.
Location: Pillar Clinical Research- Little Rock — Little Rock, Arkansas
Age range: 18 Years to 55 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (103 Sites)
Showing the first 25 of 103 sites.
- Pillar Clinical Research- Little Rock — Little Rock, Arkansas
- Clinical Innovations, Inc. dba CITrials — Bellflower, California
- Collaborative Neuroscience Research, LLC — Garden Grove, California
- Catalina Research Institute, LLC — Montclair, California
- Stanford University School of Medicine — Stanford, California
- Collaborative Neuroscience Research, LLC — Torrance, California
- Sunwise Clinical Research — Walnut Creek, California
- Institute of Living — Hartford, Connecticut
- Yale University School of Medicine — New Haven, Connecticut
- Magno Medical Research Group — Cooper City, Florida
- NextPhase Research Florida - Hollywood — Hollywood, Florida
- Innovative Clinical Research — Lauderhill, Florida
- Accel Research Sites - Maitland Clinical Research Unit — Maitland, Florida
- Wellness Research Center — Miami, Florida
- Vital Medical Research — Miami, Florida
- CLA Research — Naples, Florida
- Apg Research, Llc — Orlando, Florida
- Atlanta Center for Medical Research — Atlanta, Georgia
- Augusta University — Augusta, Georgia
- Re:Cognition Health - Chicago — Chicago, Illinois
- CBH Health — Gaithersburg, Maryland
- McLean Hospital — Belmont, Massachusetts
- Adams Clinical Watertown — Watertown, Massachusetts
- University of Massachusetts Chan Medical School — Worcester, Massachusetts
- Arch Clinical Trials — St Louis, Missouri
📞 Contact the Study Coordinator
Phone: (317) 615-4559
Email: LillyTrials@Lilly.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Schizophrenia
- Young Adults With Violent Behavior During Early Psychosis (Aim 2) — New York, New York
- Does tDCS Change Synaptic Density in the Brains of Patients With Schizophrenia — Toronto, Ontario
- Ketogenic Diet in People With Schizophrenia — Catonsville, Maryland
- Paired Associative Stimulation in the Dorsolateral Prefrontal Cortex in Patients With Schizophrenia — Toronto, Ontario
- Investigating the Muscarinic System in Schizophrenia Using Positron Emission Tomography — Toronto, Ontario
- Long-Term Real-World Safety of Cobenfy in Adults With Schizophrenia — Suwanee, Georgia
Explore by condition: All Schizophrenia clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.